Inventor · disambiguated record
Lele Zhao
Also filed as: ZHAO LELE
9 granted patents·7 pending applications·4 citations·filing 2018–2022
75Inventor score
Files withMEDSHINE DISCOVERY INC6HELIOEAST PHARMACEUTICAL CO LTD3CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD2CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD1
Top patents by PatentIndex Score
16 records- 0184US11433053B2LSD1 inhibitor and preparation method and application thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2018·Granted Sep 6, 2022·3 cites·30 claims
- 0277US11760751B2Benzo 2-azaspiro[4.4]nonane compound and use thereofHELIOEAST PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 19, 2023·1 cites·16 claims
- 0358US12024494B2Salt of LSD1 inhibitor and a polymorph thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2019·Granted Jul 2, 2024·0 cites·7 claims
- 0456US2024208945A16-carbamate substituted heteroaryl ring derivativesMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 0555US12492215B2Pyrrolotriazine compounds acting as MNK inhibitorJUMBO DRUG BANK CO LTD·Filed 2022·Granted Dec 9, 2025·0 cites·20 claims
- 0655US2024150335A1Fused ring derivatives containing 1,4-oxazepaneMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 0754US2024166610A1Substituted pyridazine phenol derivativesMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 0852US2024199571A1Thiophene compound and application thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 0950US11524941B2Pyrazole compounds as LSD1 inhibitors and applications thereofMEDSHINE DISCOVERY INC·Filed 2021·Granted Dec 13, 2022·0 cites·18 claims
- 1050US2024182457A1Oxadiazole-substituted spirocyclic compound and application thereofHELIOEAST PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1149US12479794B2Acetophenone oxime compound and application thereofMEDSHINE DISCOVERY INC·Filed 2021·Granted Nov 25, 2025·0 cites·15 claims
- 1248US2023124301A1Tricyclic compounds and use thereofHELIOEAST PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1347US2022119431A1Salt of egfr inhibitor, crystal form, and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 1445US11155559B2Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activityCHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD·Filed 2018·Granted Oct 26, 2021·0 cites·11 claims
- 1543US11390625B2Aryl-phosphorus-oxygen compound as EGFR kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jul 19, 2022·0 cites·16 claims
- 1636US11046720B2Dimethylphosphine oxide compoundGUIZHOU INOCHINI TECH CO LTD·Filed 2019·Granted Jun 29, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Lele Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →